- suggest initial treatment of dermatophyte onychomycosis with oral terbinafine (not available in HKGU) since data suggest it has greater efficacy than the alternatives and fewer serious side effects.
- Other options may be preferable in some patients, however, based on local costs of therapy or the desire to treat with pulse therapy in patients who wish to limit the total intake of pills.
- Oral itraconazole appears to be a more effective initial agent for treatment of nondermatophyte mold onychomycosis and yeast onychomycosis. It is used in the same dose regimens as that used for dermatophyte onychomycosis.
Drugs
|
Adult
|
Children
|
· Comments
|
Itraconazole (A*)
|
-Fixed dosage1
·
For fingernails – 200 mg
daily by mouth for six weeks
·
For toenails – 200 mg
daily by mouth for 12 weeks
-Pulse therapy1
·
For fingernails – 200 mg
twice daily by mouth for one week per month for two months
·
For toenails – 200 mg
twice daily by mouth for one week per month for three months
|
-Daily for one week per month (two months therapy for
fingernails; three months therapy for toenails)1:
•Less than 20 kg: 5 mg/kg daily
•20 to 40 kg: 100 mg daily
•40 to 50 kg: 200 mg daily
•More than 50 kg: 200 mg
twice daily
OR
· Child1-12 yrs: 5 mg/kg (max 200 mg) daily for 7 days; subsequent
courses repeated after 21 days interval; fingernails 2 courses; toenails 3
courses.3
· Child 12-18 yrs: either 200 mg OD for 3 months or 200 mg
BD for 7 days, subsequent course repeated after 21 days intervals;
fingernails 2 courses, toenails 3 courses.3
|
· common SE headache
and gastrointestinal upset
· Adverse effects are lower if
itraconazole is given as pulse therapy
· Asymptomatic liver function
abnormalities
· Hepatitis tends to occur with
continuous therapy usually after 4 weeks
· Monitor for therapy more than 1
month
· contraindicated in patients
with congestive cardiac failure
|
Fluconazole (A)
|
· For fingernails- 150 mg PO once weekly for 3-6 months4
· For toenail- 150-300 mg PO once weekly for 6-12 months4
|
· 3 to 6 mg/kg one
dose per week (12 to 16 weeks for fingernails; 18 to 26 weeks for toenails)1
|
· currently
not licensed for use in onychomycosis
· Clinical
cure rates were lower (28–36% for toenail infections and 76–90% for
fingernail infections)
· Common SE include
headache, skin rash, gastrointestinal complaints and insomnia
|
Griseofulvin
(B)
|
· Microsize- 1000 mg daily in single or
divided doses2. Duration:
4-6 months or longer2
|
Oral: Children >2 years2:
· Microsize: 10-20 mg/kg/day in single or 2 divided doses (maximum:
1000 mg daily). Duration: 4-6 months or longer2
|
· Mycological
cure rates for toenail infection are only 30–40%
· SE include
nausea and rashes in 8–15% of patients
· contraindicated
in pregnancy and caution against men fathering a child for 6 months after therapy
· llimitations
including lower efficacy, long treatment duration, risk of greater drug
interactions and the availability of newer antifungal agents
|
· Not available in HKGU
|
|||
Terbinafine
|
·
For fingernails – 250 mg
daily by mouth for six weeks 1
·
For toenails – 250 mg
daily by mouth for 12 weeks1
|
-Six weeks for fingernails; 12 weeks for toenails1:
•10 to 20 kg: 62.5 mg daily
•20 to 40 kg: 125 mg daily
•Above 40 kg: 250 mg daily
|
· most common SE were gastrointestinal (49%), such as nausea,
diarrhoea or taste disturbance, and dermatological events (23%) such as rash,
pruritus, urticaria or eczema
· LFT recommended in patients with history of heavy alcohol
consumption, hepatitis or haematological abnormalities
|
Amorolfine 5 % Lacquer
|
· Apply once-twice weekly until nail is
regenerated and areas are cured.4
|
· Apply to the infected nail 1-2 times weekly after filling
and cleansing; allow to dry; treat finger nails for 6 months and toe nails
for 9-12 months.3
|
· effective
in around 50% of cases of distal fingernail and toenail onychomycosis
· SE are
rare and are limited to local burning, pruritus and erythema
|
References:
- Onychomycosis. Adam O Goldstein, MD, MPH. Uptodate 2014.
- Lexicomp
- BNF For Children 2013-2014
- Tinea Unguimn. MIMS GATEWAY Disease Chart.
- British Association of Dermatologists’ guidelines for the management of onychomycosis 2014
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.